🧬 Targeting two key pathways in cancer.
A new study in hLife reports potent, broad-spectrum antitumor activity of the EGFR/c-MET bispecific antibody ALK101.
🔗 doi.org/10.1016/j.hl...
#hLife #CancerResearch
hLife, published by Elsevier, aims to translate basic research into transformative medicine that could improve human health